Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus.

Hartuis, S. Robert, M. Chouaki, T. Morio, F. Alvarez-Moreno, CA. Le Pape P. Lavergne, R.-A.

P304

Sci Rep, 2025, 16, 2515.

Antifungal and fungicide susceptibility of clinical, animal, and environmental Fusarium and Neocosmospora species from Colombia: a one-health approach.

Sáenz, V. Lizcano-Salas, A.F. Le Pape P. Celis Ramírez. A.M.

P215

Sci. Rep. 2020, 10, 6211.

In vitro immune responses of human PBMCs against Candida albicans reveals fungal and leucocyte phenotypes associated with fungal persistence.

Alvarez-Rueda, N. Rouges, C. Touahri, A. Misme-Aucouturier, B. Albassier, M. Le Pape P.

doi: 10.1038/s41598-020-63344-6

P171

Int. J. Infect. Dis. 2018, 69, 63-67.

First report of sporadic cases of Candida auris in Colombia.

Parra-Giraldo, C.M. Valderrama, S.L. Cortes-Fraile, G. Garzón, J.R. Ariza, B.E. Morio, F. Linares-Linares, M.Y. Ceballos-Garzón, A. de la Hoz, A. Hernandez, C. Alvarez-Moreno, C. Le Pape P.

doi: 10.1016/j.ijid.2018.01.034.

P161

Infect. Immun. 2017, 85, e00807-16;

Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes During Granuloma-like Formation.

Misme-Aucouturier, B. Albassier, M. Alvarez-Rueda, N. Le Pape P.

doi: 10.1128/IAI.00807-16.

Brevets

B19.

Composition topique à utiliser dans le traitement de la leishmaniose cutanée.

Auclair, C. Fellous, E. Le Pape P. Kalil-Filho, J.

Brevet WO2019043212 - 2019-03-07

B13.

Composés pyridaziniques et pyrroliques non linéaires, procédés d'obtention et applications.

Dubreuil, D. Pipelier, M. Bakkali, H. Pradère J-P. Le Pape P. Delaunay, T. Tabatchnik, A.

Brevet international CNRS PCT/FR2007/001288.